CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		9 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2023	Dec. 31, 2023
Operating activities
Net Loss	$ (4,257)	$ (23,508)	$ (28,532)	$ (9,900)
Adjustments to reconcile net loss to net cash used in operating activities:
Credit loss expense			3,761	744
Depreciation and amortization			12,779	13,775
Amortization of financing costs charged to interest expense			850	819
Amortization of right-of-use assets			1,072	2,205
Gain on debt extinguishment	(13,017)	0	(13,017)	0
Stock-based compensation expense			23,629	19,707
Change in contingent consideration			(9)	23,326
Other non-cash expense (income), net			663	(3,147)
Change in operating assets and liabilities:
Accounts receivable			14,783	18,069
Prepaid expenses and other assets			(393)	430
Accounts payable			810	(2,046)
Other accrued expenses			(7,253)	(10,954)
Partner Share liability			(15,114)	269
Consumer Incentive liability			(7,234)		$ (10,958)
Net cash used in operating activities			(13,188)	(4,313)
Investing activities
Acquisition of property and equipment			(932)	(342)
Capitalized software development costs			(8,673)	(5,207)
Business acquisitions, net of cash acquired			202	0
Net cash used in investing activities			(9,403)	(5,549)
Financing activities
Proceeds from issuance of debt			0	30,000
Settlement of contingent consideration			14,166	50,050
Principal payments of the 2018 Line of Credit			(30,000)	(11)
Principal payments of 2020 Convertible Senior Notes			(169,291)	0
Proceeds from issuance of 2024 Convertible Senior Notes			172,500	0
Proceeds from termination of capped calls related to convertible notes			115	0
Proceeds from issuance of common stock			48,634	11
Deferred equity issuance costs			0	(45)
Equity issuance costs			(190)	0
Debt issuance costs			(5,568)	0
Net cash provided by (used in) financing activities			2,034	(20,095)
Effect of exchange rates on cash, cash equivalents and restricted cash			(25)	117
Net decrease in cash, cash equivalents and restricted cash			(20,582)	(29,840)
Cash, cash equivalents, and restricted cash — Beginning of period			91,830	121,985	$ 121,985
Cash, cash equivalents, and restricted cash — End of period	71,248	92,145	71,248	92,145
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheet:
Cash and cash equivalents	71,248	92,069	71,248	92,069		$ 91,830
Restricted cash	0	76	0	76
Total cash, cash equivalents and restricted cash — End of period	71,248	92,145	71,248	92,145		$ 91,830
Supplemental disclosure of cash flow information:
Cash paid for interest			2,202	1,924
Amounts accrued for property and equipment	$ 378	$ 0	378	0
Amounts accrued for capitalized software development costs			150	0
Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below)			27,451	0
Amounts accrued for debt issuance costs			$ 354	$ 0